Center-Authored Papers

Filters: Author is Unger, Joseph M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Carson WE, Unger JM, Sosman JA, Flaherty LE, Tuthill R, Porter MJ, Thompson JA, Kempf RA, Othus M, Ribas A et al..  2014.  Adjuvant Vaccine Immunotherapy of Resected, Clinically Node-negative Melanoma: Long-Term Outcome and Impact of HLA Class I Antigen Expression on Overall Survival.. Cancer immunology research. Abstract
Hershman DL, Unger JM.  2016.  Adverse Health Effects of Intermittent vs Continuous Androgen Deprivation Therapy for Metastatic Prostate Cancer-Reply.. JAMA oncology. 2(5):686-7.
Hershman DL, Unger JM, Wright JD, Ramsey SD, Till C, Tangen CM, Barlow WE, Blanke C, Thompson IM, Hussain M.  2016.  Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer.. JAMA oncology. 2(4):453-61. Abstract
Greenlee H, Unger JM, LeBlanc M, Ramsey S, Hershman DL.  2016.  Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Stiff PJ, Unger JM, Cook JR, Constine LS, Couban S, Stewart DA, Shea TC, Porcu P, Winter JN, Kahl BS et al..  2013.  Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma.. The New England journal of medicine. 369(18):1681-90. Abstract
C
Press OW, Unger JM, Rimsza LM, Friedberg JW, LeBlanc M, Czuczman MS, Kaminski M, Braziel RM, Spier C, Gopal AK et al..  2013.  A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP-Rituximab versus CHOP + 131Iodine--Tositumomab.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(23):6624-32. Abstract
Unger JM, Barlow WE, Martin DP, Ramsey SD, LeBlanc M, Etzioni R, Hershman DL.  2014.  Comparison of Survival Outcomes Among Cancer Patients Treated In and Out of Clinical Trials.. Journal of the National Cancer Institute. Abstract
D
Lambertini M, Falcone T, Unger JM, Phillips K-A, Del Mastro L, Moore HCF.  2016.  Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. :JCO2016692582.
Van Poznak CH, Darke A, Moinpour CM, Bagramian RA, Schubert MM, Gralow JR, Wade JL, Unger JM.  2016.  Dental health status and patient-reported outcomes at baseline in patients participating in the osteonecrosis of the jaw registry study, SWOG S0702.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. Abstract
Unger JM, Hershman DL, Martin D, Etzioni RB, Barlow WE, LeBlanc M, Ramsey SD.  2015.  The diffusion of docetaxel in patients with metastatic prostate cancer.. Journal of the National Cancer Institute. 107(2) Abstract
E
Unger JM, LeBlanc M, Blanke CD.  2017.  The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US Population.. JAMA oncology. Abstract
F
Deverka PA, Lavallee DC, Desai PJ, Armstrong J, Gorman M, Hole-Curry L, O'Leary J, Ruffner B, Watkins J, Veenstra DL et al..  2012.  Facilitating comparative effectiveness research in cancer genomics: evaluating stakeholder perceptions of the engagement process.. Journal of comparative effectiveness research. 1(4):359-370. Abstract
G
Rimsza LM, LeBlanc M, Unger JM, Miller TP, Grogan TM, Persky DO, Martel RR, Sabalos CM, Seligmann B, Braziel RM et al..  2008.  Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.. Blood. 112(8):3425-33. Abstract
Moore HCF, Unger JM, Phillips K-A, Boyle F, Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS et al..  2015.  Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.. The New England journal of medicine. 372(10):923-32. Abstract
H
Moinpour CM, Hayden KA, Unger JM, Thompson IM, Redman MW, Canby-Hagino ED, Higgins BA, Sullivan JW, Lemmon D, Breslin S et al..  2008.  Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(1):112-20. Abstract
Crew KD, Albain KS, Hershman DL, Unger JM, Lo SS.  2017.  How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? NPJ breast cancer. 3:20. Abstract
I
Persky DO, Miller TP, Unger JM, Spier CM, Puvvada S, Stea DB, Press OW, Constine LS, Barton KP, Friedberg JW et al..  2015.  Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313.. Blood. 125(2):236-41. Abstract
Stasik CJ, Nitta H, Zhang W, Mosher CH, Cook JR, Tubbs RR, Unger JM, Brooks TA, Persky DO, Wilkinson ST et al..  2010.  Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma.. Haematologica. 95(4):597-603. Abstract
L
Ganz PA, Hussey MA, Moinpour CM, Unger JM, Hutchins LF, Dakhil SR, Giguere JK, Goodwin WJ, Martino S, Albain KS.  2008.  Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(8):1223-30. Abstract
Unger JM, Till C, Thompson IM, Tangen CM, Goodman PJ, Wright JD, Barlow WE, Ramsey SD, Minasian LM, Hershman DL.  2016.  Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.. Journal of the National Cancer Institute. 108(12) Abstract
M
Unger JM, Barlow WE, Hershman DL.  2016.  Measuring the Real Clinical Impact of Randomized Clinical Trials in Oncology-Reply: Beyond Citation Counts.. JAMA oncology. 2(11):1511.
Greenlee H, Crew KD, Capodice J, Awad D, Jeffres A, Unger JM, Lew DL, Hansen LK, Meyskens FL, Wade JL et al..  2015.  Methods to Standardize a Multicenter Acupuncture Trial Protocol to Reduce Aromatase Inhibitor-related Joint Symptoms in Breast Cancer Patients.. Journal of acupuncture and meridian studies. 8(3):152-8. Abstract
N
Bernstein SH, Unger JM, LeBlanc M, Friedberg J, Miller TP, Fisher RI.  2009.  Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(1):114-9. Abstract
Fisher RI, LeBlanc M, Press OW, Maloney DG, Unger JM, Miller TP.  2005.  New treatment options have changed the survival of patients with follicular lymphoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(33):8447-52. Abstract
O
Moore HCF, Unger JM, Albain KS.  2015.  Ovarian protection during adjuvant chemotherapy.. The New England journal of medicine. 372(23):2269-70.